Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0146 | -8.11111111111 | 0.18 | 0.184 | 0.1551 | 431707 | 0.17018444 | CS |
4 | -0.1756 | -51.495601173 | 0.341 | 0.379 | 0.141 | 2462933 | 0.2662548 | CS |
12 | -0.1637 | -49.741719842 | 0.3291 | 0.6559 | 0.141 | 6853036 | 0.52531567 | CS |
26 | -3.6346 | -95.6473684211 | 3.8 | 4.87 | 0.141 | 3666582 | 0.58777818 | CS |
52 | -14.7594 | -98.8917774443 | 14.9248 | 21.56 | 0.141 | 2093713 | 1.66227115 | CS |
156 | -697.2346 | -99.9762833381 | 697.4 | 971.5156 | 0.141 | 1123815 | 195.28235393 | CS |
260 | -24.9146 | -99.3405103668 | 25.08 | 2640 | 0.141 | 867789 | 272.93086857 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관